Clinical Trial: Study Evaluating ISM8969 in Healthy Adult and Elderly Participants and Obese Adult Participants at Risk of Cardiovascular Disease

U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07581431) titled 'Study Evaluating ISM8969 in Healthy Adult and Elderly Participants and Obese Adult Participants at Risk of Cardiovascular Disease' on April 10.

Brief Summary: This is a single center, phase 1, randomized, double-blind, placebo-controlled sequential study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple ascending oral doses of ISM8969 in healthy adults and elderly participants and obese adult participants at risk of cardiovascular disease.

Study Start Date: May 29

Study Type: INTERVENTIONAL

Condition: Healthy Subjects (HS) Elderly Participants Obese Adult Participants at Risk of C...